Patriot Financial Group Insurance Agency, LLC Cara Therapeutics, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$621 Million
Q1 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$8.88 - $12.77 $4,440 - $6,385	-500 Reduced 4.13%	11,595 $0
Q3 2022 Oct 31, 2022	SELL	$8.24 - $12.56 $40,788 - $62,172	-4,950 Reduced 29.04%	12,095 $113,000
Q2 2022 Jul 29, 2022	SELL	$7.45 - $13.84 $180,290 - $334,928	-24,200 Reduced 58.67%	17,045 $156,000
Q1 2022 May 11, 2022	BUY	$9.94 - $12.65 $10,437 - $13,282	1,050 Added 2.61%	41,245 $501,000
Q4 2021 Jan 10, 2022	BUY	$11.99 - $18.14 $107,010 - $161,899	8,925 Added 28.54%	40,195 $490,000

Q3 2021 Nov 24, 2021	BUY	$11.55 - $16.06 $361,168 - $502,196	31,270 New	31,270 $483,000
Q2 2020 Jul 10, 2020	SELL	$12.39 - $17.33 $2,478 - $3,465	-200 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$14.41 - $19.64 $4,323 - $5,892	-300 Reduced 60.0%	200 $4,000
Q4 2018 Feb 04, 2019	BUY	$12.45 - $23.47 $3,735 - $7,041	300 Added 150.0%	500 $7,000
Q2 2018 Aug 14, 2018	SELL	$11.6 - $19.27 $13,920 - $23,124	-1,200 Reduced 85.71%	200 $4,000
Q2 2017 Aug 08, 2017	BUY	N/A	1,400	1,400 $17,000

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

Black Rock Inc. New York, NY

3.42M
Shares

$889,554
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.48M
Shares

$645,127
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.82M
Shares

$471,915
0.03% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$442,548
0.15% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$404,625
0.01% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account